124 related articles for article (PubMed ID: 15064739)
1. Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells.
Obad S; Brunnström H; Vallon-Christersson J; Borg A; Drott K; Gullberg U
Oncogene; 2004 May; 23(23):4050-9. PubMed ID: 15064739
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the interferon-inducible p53 target gene TRIM22 (Staf50) in human T lymphocyte activation.
Obad S; Olofsson T; Mechti N; Gullberg U; Drott K
J Interferon Cytokine Res; 2007 Oct; 27(10):857-64. PubMed ID: 17970695
[TBL] [Abstract][Full Text] [Related]
3. The transcriptional repressor ZEB regulates p73 expression at the crossroad between proliferation and differentiation.
Fontemaggi G; Gurtner A; Strano S; Higashi Y; Sacchi A; Piaggio G; Blandino G
Mol Cell Biol; 2001 Dec; 21(24):8461-70. PubMed ID: 11713281
[TBL] [Abstract][Full Text] [Related]
4. Physical interaction of tumour suppressor p53/p73 with CCAAT-binding transcription factor 2 (CTF2) and differential regulation of human high-mobility group 1 (HMG1) gene expression.
Uramoto H; Izumi H; Nagatani G; Ohmori H; Nagasue N; Ise T; Yoshida T; Yasumoto K; Kohno K
Biochem J; 2003 Apr; 371(Pt 2):301-10. PubMed ID: 12534345
[TBL] [Abstract][Full Text] [Related]
5. iASPP inhibits p53-independent apoptosis by inhibiting transcriptional activity of p63/p73 on promoters of proapoptotic genes.
Cai Y; Qiu S; Gao X; Gu SZ; Liu ZJ
Apoptosis; 2012 Aug; 17(8):777-83. PubMed ID: 22538442
[TBL] [Abstract][Full Text] [Related]
6. Wild-type p53 and p73 negatively regulate expression of proliferation related genes.
Scian MJ; Carchman EH; Mohanraj L; Stagliano KE; Anderson MA; Deb D; Crane BM; Kiyono T; Windle B; Deb SP; Deb S
Oncogene; 2008 Apr; 27(18):2583-93. PubMed ID: 17982488
[TBL] [Abstract][Full Text] [Related]
7. Expression of cyclin-dependent kinase subunit 1 (Cks1) is regulated during the cell cycle by a CDE/CHR tandem element and is downregulated by p53 but not by p63 or p73.
Rother K; Li YY; Tschöp K; Kirschner R; Müller GA; Mössner J; Engeland K
Cell Cycle; 2007 Apr; 6(7):853-62. PubMed ID: 17377499
[TBL] [Abstract][Full Text] [Related]
8. Stimulated trans-acting factor of 50 kDa (Staf50) inhibits HIV-1 replication in human monocyte-derived macrophages.
Bouazzaoui A; Kreutz M; Eisert V; Dinauer N; Heinzelmann A; Hallenberger S; Strayle J; Walker R; Rübsamen-Waigmann H; Andreesen R; von Briesen H
Virology; 2006 Dec 5-20; 356(1-2):79-94. PubMed ID: 16926043
[TBL] [Abstract][Full Text] [Related]
9. Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.
Liu JH; Liu CC; Yen CC; Gau JP; Wang WS; Tzeng CH
Int J Cancer; 2009 Jul; 125(1):71-7. PubMed ID: 19291793
[TBL] [Abstract][Full Text] [Related]
10. p73 is a p53-independent, Sp1-dependent repressor of cyclin B1 transcription.
Innocente SA; Lee JM
Biochem Biophys Res Commun; 2005 Apr; 329(2):713-8. PubMed ID: 15737644
[TBL] [Abstract][Full Text] [Related]
11. The p53-family members p63 and p73 inhibit insulin-like growth factor-I receptor gene expression in colon cancer cells.
Nahor I; Abramovitch S; Engeland K; Werner H
Growth Horm IGF Res; 2005 Dec; 15(6):388-96. PubMed ID: 16181796
[TBL] [Abstract][Full Text] [Related]
12. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
Kim EJ; Park JS; Um SJ
Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772
[TBL] [Abstract][Full Text] [Related]
13. Apoptosis-stimulating protein of p53-2 (ASPP2/53BP2L) is an E2F target gene.
Chen D; Padiernos E; Ding F; Lossos IS; Lopez CD
Cell Death Differ; 2005 Apr; 12(4):358-68. PubMed ID: 15592436
[TBL] [Abstract][Full Text] [Related]
14. Pleomorphic adenoma gene-like 2 regulates expression of the p53 family member, p73, and induces cell cycle block and apoptosis in human promonocytic U937 cells.
Hanks TS; Gauss KA
Apoptosis; 2012 Mar; 17(3):236-47. PubMed ID: 22076304
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the molecular mechanisms for p53-mediated differentiation.
Chylicki K; Ehinger M; Svedberg H; Gullberg U
Cell Growth Differ; 2000 Nov; 11(11):561-71. PubMed ID: 11095245
[TBL] [Abstract][Full Text] [Related]
16. Role of the p53-homologue p73 in E2F1-induced apoptosis.
Stiewe T; Pützer BM
Nat Genet; 2000 Dec; 26(4):464-9. PubMed ID: 11101847
[TBL] [Abstract][Full Text] [Related]
17. Identification of the interleukin 4 receptor alpha gene as a direct target for p73.
Sasaki Y; Mita H; Toyota M; Ishida S; Morimoto I; Yamashita T; Tanaka T; Imai K; Nakamura Y; Tokino T
Cancer Res; 2003 Dec; 63(23):8145-52. PubMed ID: 14678968
[TBL] [Abstract][Full Text] [Related]
18. The tumor suppressor protein p53 functions similarly to p63 and p73 in activating transcription in vitro.
Mondal N; Parvin JD
Cancer Biol Ther; 2005 Apr; 4(4):414-8. PubMed ID: 15846087
[TBL] [Abstract][Full Text] [Related]
19. E2F1-mediated transcriptional inhibition of the plasminogen activator inhibitor type 1 gene.
Koziczak M; Müller H; Helin K; Nagamine Y
Eur J Biochem; 2001 Sep; 268(18):4969-78. PubMed ID: 11559366
[TBL] [Abstract][Full Text] [Related]
20. p53 induces the expression of its antagonist p73 Delta N, establishing an autoregulatory feedback loop.
Kartasheva NN; Contente A; Lenz-Stöppler C; Roth J; Dobbelstein M
Oncogene; 2002 Jul; 21(31):4715-27. PubMed ID: 12101410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
